References: Hypercalcaemia associated with cancer

Australian Medicines Handbook (AMH). Biphosphonates. Australian Medicines Handbook Pty Ltd. 2022; Updated July 2022. Accessed 23 Dec 2022. https://amhonline.amh.net.au/chapters/endocrine-drugs/drugs-affecting-bone/bisphosphonates
Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, et al. Bone health in cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2020;31(12):1650-63. https://www.ncbi.nlm.nih.gov/pubmed/32801018
Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia. N Engl J Med 2022;386(15):1443-51. https://www.ncbi.nlm.nih.gov/pubmed/35417639
Minisola S, Pepe J, Piemonte S, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ 2015;350:h2723. https://www.ncbi.nlm.nih.gov/pubmed/26037642
Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352(4):373-9. https://www.ncbi.nlm.nih.gov/pubmed/15673803
Wilcock A, Howard P, Charlesworth S eds. Palliative Care Formulary: Edition 7. 7th ed. London: Pharmaceutical Press; 2020.
Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin 2018;68(5):377-86. https://www.ncbi.nlm.nih.gov/pubmed/30240520